Seongnam-si, South Korea

Chang Young Oh


 

Average Co-Inventor Count = 5.2

ph-index = 1

Forward Citations = 12(Granted Patents)


Location History:

  • Suwon, KR (1998)
  • Seoul, KR (2000 - 2005)
  • Seongnam-si, KR (2020 - 2022)

Company Filing History:


Years Active: 1998-2022

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Chang Young Oh: Innovator in Ophthalmic Treatments

Introduction

Chang Young Oh is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of ophthalmology, particularly in the treatment of glaucoma. With a total of 5 patents to his name, his work has the potential to impact many lives.

Latest Patents

One of his latest patents is an ophthalmic composition for glaucoma treatment. This eye drop composition includes a prostaglandin analogue, a thickening agent, and a solubilizing agent, wherein the thickening agent is carboxymethylcellulose or a salt thereof, and the solubilizing agent is tyloxapol. Another significant patent is related to a method for preparing latanoprostene bunod and an intermediate therefor. This invention outlines a process for efficiently and cost-effectively preparing latanoprostene bunod while minimizing side reactions.

Career Highlights

Throughout his career, Chang Young Oh has worked with reputable companies such as Dongkook Pharmaceutical Co., Ltd. and Yonsung Fine Chemical Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Chang Young Oh has collaborated with several professionals in his field, including Kee Young Lee and Won Hun Ham. These collaborations have likely enhanced his research and development efforts.

Conclusion

Chang Young Oh is a distinguished inventor whose work in ophthalmic treatments showcases his dedication to improving healthcare. His innovative patents and collaborations reflect his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…